Skip to main content

Subhrajit Saha, M. Tech, Ph.D.

Associate Professor
Director of Basic Science Research
Radiation Oncology

Bachelor of Science, University of Calcutta
Master of Science, University of Calcutta
Master of Technology, Indian Institute of Technology (KGP)
Doctor of Philosophy, Jadavpur University

Saha Lab of Radiation Biology

Dr. Saha received his M.Tech in Biotechnology and Biochemichal Engineering from Indian Institute of Technology KGP (2001) and his Ph.D. from Jadavpur University (2006), India. Dr. Saha completed his Post Doctoral education in Department of Radiation Oncology at Albert Einstein College of Medicine where he became an Assistant Professor and started his research group in 2013. He joined KUMC in 2016 as an Assistant Professor in Department of Radiation Oncology. In 2019, he was promoted to an Associate Professor in the Department of Radiation Oncology.  He is a member of the KU Cancer Center and also has a secondary appointment in the Department of Cancer Biology.

Dr. Saha's research focuses on cancer therapeutics and improvement in survival of cancer patients undergoing radiotherapy. The eventual goal of his research is to develop novel therapeutic strategies to increase the efficacy of radiotherapy by radio-sensitizing the malignant tissue along with ameliorating the radiation toxicity on normal tissue. His laboratory is also involved in development of medical countermeasures against radiological/nuclear accidents or terrorism.

Research Highlights

Trophic role of macrophages to rescue intestinal stem cell from radiation injury during cancer therapy.

Intestinal injury is a limiting factor for definitive chemo-radiation therapy of abdominal malignancies, such as, gastric, pancreatic and colorectal cancer. Thus, tumoricidal doses of RT or chemotherapy are not administered in the treatment of abdominal tumors, resulting in poor survival and early metastatic spread. Intestinal injury limits the application of high dose stereotactic radiosurgery (SRS) in abdominal cancers. Using novel mice genetics and virus-based tools, Dr. Saha's group has already demonstrated that macrophage/myeloid population in intestinal stem cell niche is critical for intestinal epithelial homeostasis. Currently his lab is involved to determine the macrophage derived regenerative signal and specific phenotype of macrophages involved in intestinal repair following radiation injury.

Macrophages in colonic inflammation and malignancy

Pro-inflammatory macrophages promote the onset of malignancy by inducing stress-adaptive responses of the inflamed epithelium as well as cellular survival and self-renewal. The anti-inflammatory/tissue resident macrophages are primarily involved in invasion and metastasis. Dr. Saha's group is pursuing another project to determine origin, phenotype and mechanism of invasion of these macrophages in irradiated tumor tissue. The overall goal of this project is to develop candidate agents which can deplete these pro-malignant macrophages or modulate their recruitment to induce the radio-sensitivity of tumor tissue.

Last modified: Oct 10, 2019

Subhrajit Saha


Subhrajit Saha, M. Tech, Ph.D.
Associate Professor
Director of Basic Science Research

The University of Kansas Medical Center
MS 4033, 3901 Rainbow Boulevard
Kansas City, Kansas 66160

P: 913-588-1054
F: 913-588-3663